ASSURANCE ENGINEERING FOR AUTONOMOUS QUANTUM–NANO HEALTH INFRASTRUCTURE AT THE LIMIT Measurement Trust × Clinical Authority × Recoverable Infrastructure This exploratory research monograph investigates how safety evidence could be constructed for future autonomous quantum–nano health infrastructure without confusing physical sensing accuracy, AI recommendations, professional permission, clinical effectiveness, and regulatory authorization. The central research question is whether every consequential recommendation can be reconstructed from traceable measurements, interpreted with declared uncertainty, subjected to legally and professionally valid human authorization, and linked to an independently verified safe-state and recovery pathway. The monograph is a tri-coupled synthesis of three prior mother architectures: Swarm Manufacturing and Robotic Matter at the Limit, particularly chapters 72–79, for distributed-agent security and operational fault tolerance; Autonomous Quantum Health Infrastructure at the Limit, particularly chapters 25–82, for bounded decision authority, recoverable intervention architecture and successor-ready safety evidence; and Self-Calibrating Quantum Biosensing Networks at the Limit, particularly chapters 65–73, for reference trust, bounded calibration, serviceability and governance. These mother architectures supply research methods and constraints. Their combination does not demonstrate that the integrated technology is clinically effective, medically approved, or already deployed. Across 82 chapters and 12 separately paginated research studies per chapter, the work develops a versioned Claim–Argument–Evidence architecture for non-clinical quantum–nano health systems. It examines raw-to-result metrology, shared-reference errors, uncertainty propagation, model calibration and digital twins, operator authentication, explicit professional authority envelopes, fail-closed control, verification, manual override, classical backup, malicious or degraded devices, alarm fatigue, incident replay, recovery closure, lifecycle economics, fairness, privacy and independent cross-site reconstruction. Thirty physical and mathematical derivation plates separate established relations and their validity conditions from the book’s unvalidated research heuristics. The NQ-14 deployment expression is a conceptual four-gate test: adequate evidence, valid authority, verified recovery and compliance with the applicable regulatory pathway are jointly necessary. Its Boolean structure is not a proof of safety or legal status, nor can a composite index replace consequence-specific vetoes. Every chapter offers a candidate model and a three-dimensional evidence geometry. The intended verification environment uses synthetic observations and hardware-in-the-loop non-clinical simulations. Proposed trials inject inaccurate calibration references, correlated sensor faults, operator overload, unauthorized delegation, model and firmware drift, unavailable classical backup and simultaneous communication failures. Outcomes are compared with strong classical-only and human-supervised baselines under a declared test domain; unauthorized high-consequence action, missing provenance or unrecoverable state is a rejection condition even when prediction accuracy rises. The volume concludes with 200 independent Research Gates and 33 provisional Phoenix Answer Embryos. Each has an equation egg drawn from an existing physical or mathematical relationship and accompanied by a validity boundary. An accompanying Research Gates spreadsheet preserves gate questions, tests, vetoes, provenance, assurance-case claims, human authority matrices and recovery evidence so that later laboratories may reproduce, refute, revise, split or retire the proposals. SCIENTIFIC, CLINICAL AND REGULATORY BOUNDARY: This is an exploratory, non-clinical, partly template-assisted research architecture. It reports no clinical trials, medical outcomes, validation of autonomous quantum–nano therapy or regulatory clearance. AI models do not obtain permission to diagnose or treat patients through inference quality. Clinical uses would require qualified professional oversight, intended-use evidence, independent validation, ethical governance and applicable jurisdiction-specific regulatory processes. Relevant context includes BIPM/JCGM metrology guidance, IMDRF SaMD clinical evaluation documents and FDA guidance on AI device software change management, none of which is presented as approval of the proposed platform. The thirty derivation plates are research-level derivation sketches rather than complete textbook proofs; the 233 numbered equation eggs are not discoveries of 233 new physical laws. Feng Cheng-en (33) × Starli STARLI Nano–Quantum Tri-Coupling Research Series | Flagship 14 | 2026

This research-oriented project framework investigates the construction of safety and assurance evidence for autonomous quantum-nano sensing and health infrastructure, specifically adapted for environmental health monitoring and air quality assessment. Grounded in a tri-coupled synthesis of distributed-agent security, bounded decision authority, and self-calibrating quantum biosensing networks, the methodology addresses the critical challenge of maintaining measurement trust under sensor drift and environmental noise. The framework establishes a versioned Claim-Argument-Evidence (CAE) architecture to decouple physical sensing accuracy from automated recommendations, ensuring that all high-consequence interventions are traceable to calibrated physical standards. A conceptual four-gate test (NQ-14) is utilized to evaluate adequate evidence, valid authority, verified recovery, and regulatory compliance. The proposed M.Tech implementation

focuses on simulating these self-calibrating networks under simulated atmospheric disturbances, such as photochemical smog events, where sensor degradation, correlated faults, and communication failures are systematically injected. By evaluating the system against classical-only baselines, this project provides structured guidance for designing resilient, fail-closed environmental monitoring networks that maintain data integrity and operational safety under extreme operational limits.

Message: Hi FE, I need help with “ASSURANCE ENGINEERING FOR AUTONOMOUS QUANTUM–NANO HEALTH INFRASTRUCTURE AT THE LIMIT Measurement Trust × Clinical Authority × Recoverable Infrastructure This exploratory research monograph investigates how safety evidence could be constructed for future autonomous quantum–nano health infrastructure without confusing physical sensing accuracy, AI recommendations, professional permission, clinical effectiveness, and regulatory authorization. The central research question is whether every consequential recommendation can be reconstructed from traceable measurements, interpreted with declared uncertainty, subjected to legally and professionally valid human authorization, and linked to an independently verified safe-state and recovery pathway. The monograph is a tri-coupled synthesis of three prior mother architectures: Swarm Manufacturing and Robotic Matter at the Limit, particularly chapters 72–79, for distributed-agent security and operational fault tolerance; Autonomous Quantum Health Infrastructure at the Limit, particularly chapters 25–82, for bounded decision authority, recoverable intervention architecture and successor-ready safety evidence; and Self-Calibrating Quantum Biosensing Networks at the Limit, particularly chapters 65–73, for reference trust, bounded calibration, serviceability and governance. These mother architectures supply research methods and constraints. Their combination does not demonstrate that the integrated technology is clinically effective, medically approved, or already deployed. Across 82 chapters and 12 separately paginated research studies per chapter, the work develops a versioned Claim–Argument–Evidence architecture for non-clinical quantum–nano health systems. It examines raw-to-result metrology, shared-reference errors, uncertainty propagation, model calibration and digital twins, operator authentication, explicit professional authority envelopes, fail-closed control, verification, manual override, classical backup, malicious or degraded devices, alarm fatigue, incident replay, recovery closure, lifecycle economics, fairness, privacy and independent cross-site reconstruction. Thirty physical and mathematical derivation plates separate established relations and their validity conditions from the book's unvalidated research heuristics. The NQ-14 deployment expression is a conceptual four-gate test: adequate evidence, valid authority, verified recovery and compliance with the applicable regulatory pathway are jointly necessary. Its Boolean structure is not a proof of safety or legal status, nor can a composite index replace consequence-specific vetoes. Every chapter offers a candidate model and a three-dimensional evidence geometry. The intended verification environment uses synthetic observations and hardware-in-the-loop non-clinical simulations. Proposed trials inject inaccurate calibration references, correlated sensor faults, operator overload, unauthorized delegation, model and firmware drift, unavailable classical backup and simultaneous communication failures. Outcomes are compared with strong classical-only and human-supervised baselines under a declared test domain; unauthorized high-consequence action, missing provenance or unrecoverable state is a rejection condition even when prediction accuracy rises. The volume concludes with 200 independent Research Gates and 33 provisional Phoenix Answer Embryos. Each has an equation egg drawn from an existing physical or mathematical relationship and accompanied by a validity boundary. An accompanying Research Gates spreadsheet preserves gate questions, tests, vetoes, provenance, assurance-case claims, human authority matrices and recovery evidence so that later laboratories may reproduce, refute, revise, split or retire the proposals. SCIENTIFIC, CLINICAL AND REGULATORY BOUNDARY: This is an exploratory, non-clinical, partly template-assisted research architecture. It reports no clinical trials, medical outcomes, validation of autonomous quantum–nano therapy or regulatory clearance. AI models do not obtain permission to diagnose or treat patients through inference quality. Clinical uses would require qualified professional oversight, intended-use evidence, independent validation, ethical governance and applicable jurisdiction-specific regulatory processes. Relevant context includes BIPM/JCGM metrology guidance, IMDRF SaMD clinical evaluation documents and FDA guidance on AI device software change management, none of which is presented as approval of the proposed platform. The thirty derivation plates are research-level derivation sketches rather than complete textbook proofs; the 233 numbered equation eggs are not discoveries of 233 new physical laws. Feng Cheng-en (33) × Starli STARLI Nano–Quantum Tri-Coupling Research Series | Flagship 14 | 2026” in “Environmental Engineering”